Health Care & Life Sciences » Biotechnology | Scancell Holdings PLC

Scancell Holdings PLC | Ownership

Companies that own Scancell Holdings PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
City Financial Investment Co. Ltd.
21,287,775
5.49%
21,287,775
0.32%
04/20/2018
Legal & General Investment Management Ltd.
16,000,000
4.13%
0
0%
05/09/2018
ISPartners Investment Solutions AG
4,908,080
1.27%
-3,393,681
1.87%
02/16/2017

About Scancell Holdings

View Profile
Address
John Eccles House
Oxford Oxfordshire OX4 4GP
United Kingdom
Employees -
Website http://scancell.co.uk
Updated 07/08/2019
Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. It operates through ImmunoBody and Moditope technology platforms. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.